Clinical Trials Browser

Technetium Tc 99m Medronate × Genitourinary × 90 days × Clear all

NCT05924672 2026-01-14

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Phase 2 Active not recruiting

Prostatic Neoplasms